Experimental Cancer Trial Finder - FAQs
As the EC Trial Finder is not a research database/project, HRA/Ethics approval is not needed. EC Trial Finder is a searchable register of trials.
Cancer Research UK is leading on this project on behalf of the ECMC network. The ECMC programme office is delivering the project in collaboration with the CRUK technology department and the ECMC network.
The project is led by Cancer Research UK, there is no commercial involvement.
Basic trial information is pulled into the database and updated by the local NHS Location EC Trial Finder Coordinator. It includes high-level trial information and does not include any patient or confidential information.
Information is requested directly from the NHS Location EC Trial Finder coordinator using a monthly clinical trial data template. No action is required from the trial sponsor.
The information includes:
- ECMC Location (Lead site and Recruiting)
- A unique trial ID -IRAS no#
- Full trial title
- Treatment type
- Hyperlink to external trial record (e.g. clinicaltrials.gov.uk)
- Trial Status and recruitment status (closed trials are removed from the database)
- Predicted open date for trials in set up if provided (optional)
- Molecular stratification marker (markers associated to the patient eligibility criteria)
- Principle Investigator name and contact details
- Site’s primary recruitment contact role, name and contact details
- Site’s secondary recruitment contact role, name and contact details
- Notes from the site (optional) that the site wants to be published that could be helpful for the recruitment
- Visibility of your sponsored trial information across the ECMC clinical network
- Increased opportunity for patient referrals
- Increased opportunity to enhance patient recruitment volumes
- Increased opportunity to improve patient recruitment timelines
- Increased opportunity to improve patient referrals and recruitment for trials that can be hard to recruit to, i.e. stratified trials low patient population
Access is currently restricted to clinical staff within the ECMC network during the alpha testing phase.
The Experimental Cancer Medicine Centre (ECMC) network includes world-leading scientists and clinicians, who drive the discovery, development and testing of new treatments to combat cancer. The centres are jointly funded by Cancer Research UK, the National Institute for Health Research in England and the Departments of Health for Scotland, Wales and Northern Ireland.
If you still have questions, please do get in touch: email@example.com